Relief Therapeutics Holding SA (RLFTF)
1.39
-0.01
(-0.71%)
USD |
OTCM |
May 03, 16:00
Relief Therapeutics 1 Year Total Returns (Daily): -83.05% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -83.05% |
May 02, 2024 | -80.34% |
May 01, 2024 | -81.48% |
April 30, 2024 | -80.56% |
April 29, 2024 | -80.00% |
April 26, 2024 | -80.41% |
April 25, 2024 | -80.67% |
April 24, 2024 | -81.17% |
April 23, 2024 | -80.92% |
April 22, 2024 | -80.92% |
April 19, 2024 | -82.10% |
April 18, 2024 | -82.98% |
April 17, 2024 | -82.32% |
April 16, 2024 | -83.62% |
April 15, 2024 | -83.98% |
April 12, 2024 | -83.14% |
April 11, 2024 | -82.74% |
April 10, 2024 | -81.71% |
April 09, 2024 | -82.32% |
April 08, 2024 | -82.28% |
April 05, 2024 | -81.48% |
April 04, 2024 | -82.98% |
April 03, 2024 | -85.05% |
April 02, 2024 | -84.00% |
April 01, 2024 | -84.11% |
Date | Value |
---|---|
March 28, 2024 | -82.14% |
March 27, 2024 | -79.05% |
March 26, 2024 | -80.98% |
March 25, 2024 | -80.00% |
March 22, 2024 | -80.02% |
March 21, 2024 | -81.69% |
March 20, 2024 | -79.36% |
March 19, 2024 | -80.95% |
March 18, 2024 | -80.95% |
March 15, 2024 | -80.50% |
March 14, 2024 | -80.20% |
March 13, 2024 | -81.33% |
March 12, 2024 | -81.93% |
March 11, 2024 | -81.49% |
March 08, 2024 | -83.30% |
March 07, 2024 | -82.60% |
March 06, 2024 | -82.90% |
March 05, 2024 | -83.98% |
March 04, 2024 | -82.55% |
March 01, 2024 | -82.16% |
February 29, 2024 | -83.36% |
February 28, 2024 | -82.89% |
February 27, 2024 | -79.89% |
February 26, 2024 | -81.35% |
February 23, 2024 | -80.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.77%
Minimum
Jun 14 2022
828.9%
Maximum
Jun 02 2021
-11.07%
Average
-77.55%
Median
May 23 2023
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 29.19% |
CRISPR Therapeutics AG | 13.62% |
Addex Therapeutics Ltd | -38.14% |
NLS Pharmaceutics Ltd | -89.70% |
Molecular Partners AG | -41.47% |